Results 21 to 30 of about 9,354,751 (270)

Reactivity against complementary proteinase-3 is not increased in patients with PR3-ANCA-associated vasculitis. [PDF]

PLoS ONE, 2011
The etiology of anti-neutrophil cytoplasmic antibodies (ANCA) associated vasculitides (AAV) is unknown, but the association between infections and autoimmunity has been studied extensively.
Henko Tadema, Cees G M Kallenberg, Coen A Stegeman, Peter Heeringa   +3 more
doaj   +1 more source

Renal thrombotic microangiopathy in an ANCA-associated vasculitis [PDF]

Journal of Nephropathology, 2019
Anti-neutrophil cytoplasmic antibody (ANCA) disease remains a diagnostic challenge due to the heterogeneity of possible clinical presentations. We present the case of a 63-year-old white male with a known history of ANCA-associated vasculitis (AAV) with ...
Ana Teresa Domingos, Sara Barreto, Eduarda Carias, Ana Cabrita, Helena Viana, Mário Góis   +5 more
doaj   +1 more source

The effects of plasma exchange in patients with ANCA-associated vasculitis: an updated systematic review and meta-analysis

British medical journal, 2022
Objective To assess the effects of plasma exchange on important outcomes in anti-neutrophil cytoplasm antibody (ANCA)-associated vasculitis (AAV). Design Systematic review and meta-analysis of randomised controlled trials. Eligibility criteria Randomised
M. Walsh, D. Collister, L. Zeng, P. Merkel, C. Pusey, G. Guyatt, Chen Au Peh, W. Szpirt, T. Ito-Hara, D. Jayne   +9 more
semanticscholar   +1 more source

ANCA associated vasculitis subtypes: Response (response to letter) [PDF]

, 2022
Many thanks for the opportunity to respond to the interesting letter to the Editor from Merkel, Jayne, and Bekker, with regard to our publication “ANCA Associated Vasculitis Subtypes: Recent Insights and Future Perspectives”.1In the management section of
Robson, Joanna C, Robson, Joanna C., Austin, Keziah, Janagan, Shalini, Crawshaw, Helena, McAdoo, Stephen, Wells, Matthew   +6 more
core   +1 more source

Long-term outcomes and prognostic factors for survival of patients with ANCA-associated vasculitis.

Nephrology, Dialysis and Transplantation, 2023
BACKGROUND Despite newer treatments with immunosuppressive agents, there still exists a considerable morbidity and mortality risk among patients with antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis (AAV).
Beatriz Sánchez Álamo, L. Moi, I. Bajema, Mikkel Faurshou, O. Flossmann, T. Hauser, Z. Hruskova, D. Jayne, R. Luqmani, A. Mahr, A. Åkesson, K. Westman   +11 more
semanticscholar   +1 more source

Rituximab versus azathioprine for maintenance of remission for patients with ANCA-associated vasculitis and relapsing disease: an international randomised controlled trial

Annals of the Rheumatic Diseases, 2023
Objective Following induction of remission with rituximab in anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV) relapse rates are high, especially in patients with history of relapse.
Rona M. Smith, R. Jones, U. Specks, S. Bond, M. Nodale, R. Al-Jayyousi, J. Andrews, A. Bruchfeld, B. Camilleri, S. Carette, C. Cheung, V. Derebail, T. Doulton, A. Ferraro, Lindsy J. Forbess, S. Fujimoto, S. Furuta, Ora Gewurz-Singer, L. Harper, T. Ito-Ihara, N. Khalidi, R. Klocke, C. Koening, Y. Komagata, C. Langford, P. Lanyon, R. Luqmani, Carol A. McAlear, L. Moreland, K. Mynard, P. Nachman, C. Pagnoux, C. Peh, C. Pusey, D. Ranganathan, Rennie L. Rhee, R. Spiera, A. Sreih, V. Tesař, Giles D. Walters, C. Wroe, D. Jayne, P. Merkel   +42 more
semanticscholar   +1 more source

ANCA-associated vasculitis overlaps with systemic sclerosis: a case report and literature review

European Journal of Medical Research, 2021
Background Systemic sclerosis (SSc) and anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) both affect the kidney and may cause renal failure. Treatment of AAV is dramatically different from that of SSc renal crisis (SRC).
Rui Wu, Jiang Su, Yu-rong Zou, Jing Zhu
doaj   +1 more source

Autoantibodies Against Lysosome Associated Membrane Protein-2 (LAMP-2) in Pediatric Chronic Primary Systemic Vasculitis

Frontiers in Immunology, 2021
BackgroundAnti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a small vessel vasculitis in adults and children that commonly affects the kidneys.
Kristen M. Gibson, Kristen M. Gibson, Renate Kain, Raashid A. Luqmani, Colin J. Ross, David A. Cabral, David A. Cabral, Kelly L. Brown, Kelly L. Brown, Kelly L. Brown   +9 more
doaj   +1 more source

Effect of Reduced-Dose vs High-Dose Glucocorticoids Added to Rituximab on Remission Induction in ANCA-Associated Vasculitis: A Randomized Clinical Trial.

Journal of the American Medical Association (JAMA), 2021
Importance The current standard induction therapy for antineutrophil cytoplasm antibody (ANCA)-associated vasculitis is the combination of high-dose glucocorticoids and cyclophosphamide or rituximab.
S. Furuta, D. Nakagomi, Yoshihisa Kobayashi, M. Hiraguri, T. Sugiyama, K. Amano, T. Umibe, H. Kono, K. Kurasawa, Y. Kita, R. Matsumura, Y. Kaneko, K. Ninagawa, K. Hiromura, S. Kagami, Y. Inaba, Hideki Hanaoka, K. Ikeda, H. Nakajima, Kengo Nagashima, Yohei Kawasaki, Yoshito Ozawa, Kokoro Someya, Asako Kono, Daisuke Kashiwakuma, Hiroshi Watanabe, Tamao Nakashita, Norihiro Mimura, Yoshihiro Oya, Michio Fujiwara, Ichiei Narita, Yoko Wada, Takeshi Nakatsue, Noriyoshi Ogawa, D. Suzuki, Kurumi Asako, Hirotoshi Kikuchi, S. Uchida, Yoshihide Fujigaki, Toru Sakairi, Reika Maezawa, Hirotoshi Kawashima, A. Matsuki, Mieko Yamagata, Yuichiro Ohta, Ryota Sakai, Tomonori Ishii, Atsushi Kawakami, T. Sumida, N. Watanabe, Tatsuya Atsumi, Shun Tanimura, Atsushi Kumanogoh, Takahiko Sugihara, Hideyuki Iwai, Yoshiya Tanaka, Atsushi Komatsuda, Kaori Ito, Yoshihiro Shimojima, Iwao Sekigawa, Yukiko Takakuwa, Yuichi Makino, Ryusuke Yoshimi, Taichi Hayashi, Hiroshi Otani   +64 more
semanticscholar   +1 more source

Prevalence and clinical association of the presence of anti-neutrophilic cytoplasmic antibody in systemic sclerosis

Archives of Medical Science, 2020
Introduction Anti-neutrophilic cytoplasmic antibody (ANCA) has been reported in systemic sclerosis (SSc). Some clinical features of SSc can also be presented with ANCA-associated vasculitis.
Ajanee Mahakkanukrauh, Siraphop Suwannaroj, Ratanavadee Nanagara, Chingching Foocharoen   +3 more
doaj   +1 more source